Published in Bioorg Med Chem Lett on July 23, 2001
Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet (2000) 7.06
Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology (2000) 3.32
Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science (1999) 3.22
Brain areas involved in perception of biological motion. J Cogn Neurosci (2000) 3.21
The metabolism of a poly(A) minus mRNA fraction in HeLa cells. Cell (1974) 3.17
Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge. J Virol (1998) 3.07
Attenuated vesicular stomatitis viruses as vaccine vectors. J Virol (1999) 3.04
Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. J Med Chem (1988) 3.04
The effect of strength and endurance training on gait, balance, fall risk, and health services use in community-living older adults. J Gerontol A Biol Sci Med Sci (1997) 2.83
Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis Rheum (2002) 2.75
Hydropathy in England 1840-70. Med Hist (1981) 2.74
Intramolecular masking of nuclear import signal on NF-AT4 by casein kinase I and MEKK1. Cell (1998) 2.57
Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist. Proc Natl Acad Sci U S A (1986) 2.34
Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family. J Biol Chem (1999) 2.33
Transcription of the adenovirus genome by an -amanitine-sensitive ribonucleic acid polymerase in HeLa cells. J Virol (1972) 2.29
Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am J Pathol (2001) 2.29
Population pharmacokinetics of mefloquine in patients with acute falciparum malaria. Clin Pharmacol Ther (1999) 2.16
HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteins. Biochem Biophys Res Commun (1988) 2.14
A distinct RNA polymerase activity, synthesizing 5-5 s, 5 s and 4 s RNA in nuclei from adenovirus 2-infected HeLa cells. J Mol Biol (1972) 2.06
A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260. Eur J Pharmacol (1989) 1.95
Heterogeneity of histamine H1-receptors: species variations in [3H]mepyramine binding of brain membranes. J Neurochem (1979) 1.72
Changes in body composition after jejunoileal bypass in morbidity obese patients. Am J Surg (1972) 1.71
Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem Biophys Res Commun (1992) 1.69
Domiciliary nebulisers in asthma: a district survey. Br Med J (Clin Res Ed) (1985) 1.65
Maternal transmission of acquired immune deficiency syndrome. Pediatrics (1984) 1.60
HIV-1 vaccine development: constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAb. Biochemistry (2003) 1.59
Myofibril degeneration caused by tropomodulin overexpression leads to dilated cardiomyopathy in juvenile mice. J Clin Invest (1998) 1.59
Transmission intensity and Plasmodium falciparum diversity on the northwestern border of Thailand. Am J Trop Med Hyg (1998) 1.54
Expression cloning of a human B1 bradykinin receptor. J Biol Chem (1994) 1.54
Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin. Proc Natl Acad Sci U S A (1986) 1.53
Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1997) 1.52
Uncomplicated HL-A matched sibling bone marrow graft for combined immune deficiency. Br Med J (1972) 1.49
Gene encoding the beta subunit of S100 protein is on chromosome 21: implications for Down syndrome. Science (1988) 1.49
A biochemical and kinetic analysis of the interleukin-1 receptor. Evidence for differences in molecular properties of IL-1 receptors. J Biol Chem (1987) 1.47
Selective dorsal rhizotomy: efficacy and safety in an investigator-masked randomized clinical trial. Dev Med Child Neurol (1998) 1.46
Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3673 patients. Bull World Health Organ (1995) 1.43
Hypertrophic defect unmasked by calcineurin expression in asymptomatic tropomodulin overexpressing transgenic mice. Cardiovasc Res (2000) 1.42
Treatment of the first known case of king cobra envenomation in the United Kingdom, complicated by severe anaphylaxis. Anaesthesia (2007) 1.42
Effect of interferon on the induction of human monocyte secretion of interleukin-1 activity. Immunology (1985) 1.40
Targeted disruption of a B2 bradykinin receptor gene in mice eliminates bradykinin action in smooth muscle and neurons. J Biol Chem (1995) 1.40
Cyclopsychotride A, a biologically active, 31-residue cyclic peptide isolated from Psychotria longipes. J Nat Prod (1994) 1.40
A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus. Science (1985) 1.39
A comparison of subjective and objective measures of reduction of psoriasis with the use of ultrasound, reflectance colorimetry, computerized video image analysis, and nitric oxide production. J Am Acad Dermatol (1997) 1.39
Radar Echoes from Venus: Advances in several arts made possible this experiment in radio astronomy performed during the IGY. Science (1959) 1.38
Differential pharmacology of cloned human and mouse B2 bradykinin receptors. Mol Pharmacol (1994) 1.37
Histamine H1 receptors identified in mammalian brain membranes with [3H]mepyramine. Proc Natl Acad Sci U S A (1978) 1.37
Indoleamine 2,3-dioxygenase, an emerging target for anti-cancer therapy. Curr Cancer Drug Targets (2009) 1.32
Bioactive conformation of luteinizing hormone-releasing hormone: evidence from a conformationally constrained analog. Science (1980) 1.32
The effects of calcium supplementation (milk powder or tablets) and exercise on bone density in postmenopausal women. J Bone Miner Res (1995) 1.31
Benzodiazepine gastrin and brain cholecystokinin receptor ligands: L-365,260. J Med Chem (1989) 1.31
Regulation of monocyte integrin expression by beta-family chemokines. J Immunol (1994) 1.30
Permselectivity of the glomerular capillary wall to macromolecules. I. Theoretical considerations. Biophys J (1975) 1.30
Photoreceptor degeneration. Possible autoimmune disorder. Arch Ophthalmol (1983) 1.29
Histamine H1-receptors in brain labeled with 3H-mepyramine. Eur J Pharmacol (1978) 1.27
Low intensity resistance exercise for breast cancer patients with arm lymphedema with or without compression sleeve. Lymphology (2005) 1.26
Identification of soluble interleukin-1 binding protein in cell-free supernatants. Evidence for soluble interleukin-1 receptor. J Biol Chem (1990) 1.25
Leukocyte-transforming agent: prolonged excretion by patients with mononucleosis and excretion by normal individuals. J Infect Dis (1973) 1.20
The long term effect of sphincter preserving operations for rectal carcinoma on function of the anal sphincter in man. Br J Surg (1980) 1.19
Characteristics of histamine H1-receptors in peripheral tissues labeled with [3H]mepyramine. J Pharmacol Exp Ther (1979) 1.18
Steroid anesthetics and naturally occurring analogs modulate the gamma-aminobutyric acid receptor complex at a site distinct from barbiturates. J Pharmacol Exp Ther (1989) 1.18
Histamine H1-receptor binding sites in guinea pig brain membranes: regulation of agonist interactions by guanine nucleotides and cations. J Neurochem (1980) 1.16
Congenic mice reveal sex-specific genetic regulation of femoral structure and strength. Calcif Tissue Int (2003) 1.15
Modulation of aortic protein phosphatase activity by polylysine. Proc Soc Exp Biol Med (1984) 1.15
Acceleration of plasma bicarbonate conversion to carbon dioxide by pulmonary carbonic anhydrase. Science (1978) 1.15
Transformation of human leucocytes by throat washing from infectious mononucleosis patients. Nature (1971) 1.15
A super active cyclic hexapeptide analog of somatostatin. Life Sci (1984) 1.14
Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression. Carcinogenesis (2000) 1.14
Prevalence of oropharyngeal excreters of leukocyte-transforming agents among a human population. N Engl J Med (1973) 1.13
Nonpeptide angiotensin II antagonists derived from 1H-pyrazole-5-carboxylates and 4-aryl-1H-imidazole-5-carboxylates. J Med Chem (1993) 1.13
The fate of pro-TNF-alpha following inhibition of metalloprotease-dependent processing to soluble TNF-alpha in human monocytes. J Immunol (1997) 1.13
The phospholamban phosphatase associated with cardiac sarcoplasmic reticulum is a type 1 enzyme. Arch Biochem Biophys (1992) 1.11
Prediction of thoracic and lumbar vertebral body compressive strength: correlations with bone mineral density and vertebral region. Bone (1995) 1.11
Modification of tumor necrosis factor-alpha (TNF-alpha) production by the Na(+)-dependent HCO3- cotransport in lipopolysaccharide-activated human monocytes. Immunopharmacology (1995) 1.11
Recurrence of infectious mononucleosis. Lancet (1980) 1.11
Structure of lipid tubules formed from a polymerizable lecithin. Biophys J (1985) 1.11
A phospholamban protein phosphatase activity associated with cardiac sarcoplasmic reticulum. J Biol Chem (1986) 1.10
Letter: What is the determinant for susceptibility to infectious mononucleosis? N Engl J Med (1975) 1.09
Triazolinone biphenylsulfonamides as angiotensin II receptor antagonists with high affinity for both the AT1 and AT2 subtypes. J Med Chem (1994) 1.09
The use of the long gamma nail in proximal femoral fractures. Injury (2005) 1.08
Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS Clinical Trials Group study a5199, the International Neurological Study. Clin Infect Dis (2012) 1.08
Activation and distribution of inflammatory cells in the mouse uterus during the preimplantation period. J Immunol (1992) 1.08
Association between villous atrophy in rheumatoid arthritis and a rheumatoid factor and gliadin-specific IgG. Lancet (1988) 1.08
Specific interaction of some cartilage proteinpolysaccharides with freshly precipitating calcium phosphate. J Biol Chem (1967) 1.08
Herpes simplex encephalitis in an anergic patient. Am J Med (1973) 1.06
Triazolinones as nonpeptide angiotensin II antagonists. 1. Synthesis and evaluation of potent 2,4,5-trisubstituted triazolinones. J Med Chem (1993) 1.05
Epstein-Barr virus genotypes associated with nasopharyngeal carcinoma in southern China. Virology (1990) 1.05
On the nature of the "lipovirus". J Exp Med (1966) 1.05
Topographical variation within the articular cartilage and subchondral bone of the normal ovine knee joint: a histological approach. Osteoarthritis Cartilage (1995) 1.05
Role of the perinodal region in atrioventricular nodal reentry: evidence in an isolated rabbit heart preparation. J Am Coll Cardiol (1983) 1.04
Spasticity: quantitative measurements as a basis for assessing effectiveness of therapeutic intervention. Arch Phys Med Rehabil (1989) 1.04
Comprehensive analysis of energy storing prosthetic feet: Flex Foot and Seattle Foot Versus Standard SACH foot. Arch Phys Med Rehabil (1993) 1.04
In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist. J Pharmacol Exp Ther (1987) 1.03
Cutting edge: a dominant negative form of TNF-alpha converting enzyme inhibits proTNF and TNFRII secretion. J Immunol (1999) 1.03
Characterization of the binding of [3H]-(+/-)-L-364,718: a new potent, nonpeptide cholecystokinin antagonist radioligand selective for peripheral receptors. Mol Pharmacol (1986) 1.02
Genetic polymorphism of natural Epstein-Barr virus isolates from infectious mononucleosis patients and healthy carriers. J Virol (1988) 1.02
Identification of IL-1 receptors on human monocytes. J Immunol (1989) 1.02